Document is current
Any future updates will be listed below
-
Authors
Zhan, Jianhua
Xue, Jinhui
Wu, Lin
Zhang, Zhiye
Wang, Qiming
Ma, Yuxiang
Huang, Yan
Yang, Yunpeng
Zhao, Yuanyuan
Fang, Wenfeng
Zhang, Yang
Liu, Qianwen
Xu, Wen
Yang, Yan
Chen, Zhenming
Song, Baili
Sun, Danni
Sun, Xia
Gao, Peng
Zhao, Hongyun
Zhang, Li
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05435248 at ClinicalTrials.govumin000006045 at UMIN JapanDocuments that mention this clinical trial
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer
https://doi.org/10.1186/s12967-025-06613-0
Documents that mention this clinical trial
Adverse events in India’s Ayush interventions for cervical and lumbar spondylosis: a systematic review
https://doi.org/10.1186/s40001-024-01985-3
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
https://doi.org/10.1007/s10147-023-02402-1
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
Robot-assisted mobilisation in the intensive care unit: does it offer relief to mobilising specialists? A qualitative longitudinal study at a German university hospital
https://doi.org/10.1007/s44155-024-00074-4
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer
https://doi.org/10.1186/s12967-025-06613-0
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272789, 82241232, 82473346)
Guangzhou Science and Technology Project (202206010141)
Noncommunicable Chronic Diseases National Science and Technology Major Project (2024ZD0519700)
Guangzhou Science and Technology Bureau Basic and Applied Basic Research Project (SL2022A04J01033)
Young Talents Program of Sun Yat-sen University Cancer Center (YTP-SYSUCC-0094)
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 14 May 2025
First Online: 4 June 2025
Declarations
:
: This clinical trial was approved by the Ethics Committee of Sun Yat-sen University Cancer Center (A2021-184–01). Informed consent was provided by all recruited subjects prior to the study.
: Written informed consent for publication of individual data was obtained from all patients.
: W.X., Yan Yang, Z.C., B.S., D.S., X.S. and P.G. are the employees of Hansoh Pharmaceutical Group Co. Ltd., Shanghai, China. Other authors declare that they have no competing interests.
